10 Recruiting Neuroendocrine Tumors Phase 2 Clinical Trials
Active phase 2 studies for neuroendocrine tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Neuroendocrine Tumors studiesPhase 2 Studies for Neuroendocrine Tumors
π΅ Active, Not Recruiting Phase2
Targeted Alpha-emitter Therapy of PRRT NaΓ―ve and Previous PRRT Neuroendocrine Tumor Patients
π Rocky Mountain Cancer Center β Denver, Colorado
View Study & Checklist β π΅ Active, Not Recruiting Phase2
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
π University of Alberta Hospital β Edmonton, Alberta
View Study & Checklist β π΅ Active, Not Recruiting Phase2
Personalized PRRT of Neuroendocrine Tumors
π CHU de QuΓ©bec - UniversitΓ© Laval β QuΓ©bec, Quebec
View Study & Checklist β π’ Recruiting Phase2
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
π Royal North Shore Hospital β Sydney, New South Wales
View Study & Checklist β π’ Recruiting Phase2
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
π University of California, San Francisco β San Francisco, California
View Study & Checklist β π’ Recruiting Phase2
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
π Holden Comprehensive Cancer Center at the University of Iowa β Iowa City, Iowa
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
π Cross Cancer Institute β Edmonton, Alberta
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
π Emory University β Atlanta, Georgia
View Study & Checklist β π’ Recruiting Phase2
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
π Huntsman Cancer Institute at University of Utah β Salt Lake City, Utah
View Study & Checklist β π’ Recruiting Phase2
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
π University of Alberta β Edmonton, Alberta
View Study & Checklist β